To address the role of the CYP4/20-HETE/GPR75 axis, we measured the amount and the synthesis of 20-HETE in patients with CLD, specifically during the progression of MASLD. This evidence concerns the gene GPR75 and metabolic dysfunction-associated steatotic liver disease.